Lakshmi Rajdev, discusses the efficacy of pembrolizumab (Keytruda) plus chemotherapy in patients with esophageal cancer.
Lakshmi N. Rajdev, MD
Advertisement
Articles by Lakshmi N. Rajdev, MD
Lakshmi N. Rajdev, MD, discusses the use of somatostatin analogs in patients with neuroendocrine tumors.
Lakshmi N. Rajdev, MD, an associate professor, Department of Medicine (Oncology), at Albert Einstein College of Medicine, Montefiore Medical Center, discusses the difference between cancers and carcinomas in neuroendocrine tumors (NETs).
Advertisement
Latest Updated Articles
Dr. Rajdev on the Efficacy of Pembrolizumab/Chemotherapy in Esophageal CancerPublished: April 2nd 2021 | Updated:
Dr. Rajdev on the Difference Between Cancers and Carcinomas in NETsPublished: November 6th 2019 | Updated:
Dr. Rajdev on the Use of Somatostatin Analogs in Neuroendocrine TumorsPublished: November 23rd 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5